483 Armstrong Pharmaceuticals Jun 2012

483 Armstrong Pharmaceuticals Jun 2012

Debra Emerson FDA, Mary-Jeanet Mcgarry FDA$119.00 - Available Now

FDA investigators audited the Armstrong Pharmaceuticals - Canton, MA, United States facility and issued 2 inspectional observations (via FDA 483) on 14 Jun 2012.

Product details

  • Category: Human Drugs
  • Number of Observations: 2
  • Inspection end: 14 Jun 2012
  • Location: Canton, United States
  • FEI: 3007009553
Add To Cart